Literature DB >> 22920633

Muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis.

Makoto Uchino1, Satoshi Yamashita, Katsuhisa Uchino, Akira Mori, Akio Hara, Tomohiro Suga, Tomoo Hirahara, Tatsuya Koide, En Kimura, Taro Yamashita, Akihiko Ueda, Ryoichi Kurisaki, Junko Suzuki, Shoji Honda, Yasushi Maeda, Teruyuki Hirano, Yukio Ando.   

Abstract

OBJECTIVE: The characteristic pathological muscular findings of polymyositis (PM) and dermatomyositis (DM) have been shown to reflect their different pathogeneses. Here, we characterized the muscle biopsy findings of PM and DM patients with or without malignancy.
METHODS: We evaluated the muscle biopsy findings of 215 consecutive PM and DM patients admitted to our hospital between 1970 and 2009. Pathology of the lesion biopsy sections was classified into 3 types: endomysial infiltration-type, perivascular infiltration-type, and rare-infiltrative-type.
RESULTS: There was no difference between the muscle pathology of PM patients with and without malignancy. However, the incidence of rare-infiltrative type muscle pathology in DM patients with malignancy was significantly higher than in those without such tumors (p=0.0345).
CONCLUSION: The incidence of rare-infiltrative type muscle pathology may be a predictive marker of DM with malignancy.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920633     DOI: 10.1016/j.clineuro.2012.07.019

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

Review 1.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 2.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 3.  Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.

Authors:  Xin Lu; Hanbo Yang; Xiaoming Shu; Fang Chen; Yinli Zhang; Sigong Zhang; Qinglin Peng; Xiaolan Tian; Guochun Wang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

4.  Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy.

Authors:  Na Ri Kim; Eon Jeong Nam; Jong Wan Kang; Hyun Seok Song; Churl Hyun Im; Young Mo Kang
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

Review 5.  Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?

Authors:  Urmi Khanna; Fabrizio Galimberti; Yumeng Li; Anthony P Fernandez
Journal:  Ann Transl Med       Date:  2021-03

Review 6.  Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.

Authors:  Aleksandra H Opinc; Joanna S Makowska
Journal:  Biomolecules       Date:  2022-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.